Frequently Asked Question
Multiple clinical studies and ongoing trials demonstrate that MRI-guided ablation provides excellent visibility, strong procedural safety, and the potential to reduce repeat procedures. By enabling direct lesion assessment and eliminating radiation, iCMR represents a next-generation approach to electrophysiology. Programs such as the VISABL-AFL and VISABL-VT trials continue to expand the evidence base for broader indications.
See the following studies:
- Clinical workflow and applicability of electrophysiological cardiovascular magnetic resonance-guided radiofrequency ablation of isthmus-dependent atrial flutter
- Safety, Efficacy, and 2-Year Outcomes of Cardiovascular Magnetic Resonance-Guided Ablation of Isthmus-Dependent Atrial Flutter
- Magnetic resonance imaging–guided conventional catheter ablation of isthmus-dependent atrial flutter using active catheter imaging
More Frequently Asked Questions
Back to All →
What’s the current regulatory status (EU/US) and which indications are approved?
Imricor’s Vision-MR Ablation Catheter 2.0, Vision-MR Diagnostic Catheter, Vision-MR Dispersive Electrode, Advantage-MR EP Recorder/Stimulator System, and NorthStar Mapping System hold...
How can hospitals calculate ROI and throughput benefits?
Hospitals measure ROI by combining several factors: decreased repeat procedures, lower occupational-health costs, improved staff retention, and the ability to...
What are the capital and operational cost considerations?
Building an interventional cardiac MRI (iCMR) program involves both facility upgrades and specialized equipment investments. Hospitals typically budget for MRI...